Ignite Creation Date:
2025-12-24 @ 4:30 PM
Ignite Modification Date:
2026-01-01 @ 8:27 PM
Study NCT ID:
NCT04721366
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2021-01-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-17
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-21
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-28
Last Update Post Date:
2024-03-29
Last Update Post Date Type:
ACTUAL